ArticleFrontiers in oncology2022

Safety, tolerability, and pharmacokinetics/pharmacodynamics of JMT103 in patients with bone metastases from solid tumors.

Xu Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.